STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LIN Form 4: Director Stephen Angel Gifts 25,000 Linde Shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stephen F. Angel, a director of Linde plc (LIN), reported a change in beneficial ownership on Form 4. The filing shows a disposition on 08/18/2025 of 25,000 ordinary shares reported as a charitable gift with no market transaction and a $0 price. After the reported transaction the reporting person holds 455,542.502 ordinary shares directly and additional indirect holdings through trusts and a 401(k), including 71,029 shares via a 2010 Descendants Trust and other indirect interests. The filing also lists multiple outstanding restricted stock units and stock options with specified grant/expiration dates and share amounts.

Positive

  • Transaction classified as a charitable gift, indicating no market sale occurred
  • Substantial retained ownership: 455,542.502 direct shares plus meaningful indirect holdings
  • Transparent disclosure of RSUs and option schedules with vesting and expiration details

Negative

  • Direct holdings reduced by 25,000 shares following the charitable disposition
  • Filing does not state the value of the gifted shares, limiting assessment of financial impact

Insights

TL;DR Minor non-market disposal for charity; overall economic interest remains substantial and equity incentives remain in force.

The 25,000-share disposal is reported as a charitable gift, not a sale, and the reporting person retains a sizeable direct position of 455,542.502 shares plus meaningful indirect holdings and long-dated option and RSU grants. The presence of numerous RSUs and options indicates ongoing alignment with shareholder outcomes, while the disposal modestly reduces direct share count but does not materially alter control or voting influence based on disclosed amounts.

TL;DR Transaction is routine and disclosed appropriately under Section 16; governance impact appears limited.

The filing properly classifies the transaction as a charitable gift and documents holdings across direct and indirect vehicles, including descendants' trusts and deferred payouts. Documentation of vesting schedules and exercise terms for options and RSUs supports transparency. No indication of insider trading or policy breach is evident from the reported items; the filing reinforces standard disclosure practices for directors.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ANGEL STEPHEN F

(Last) (First) (Middle)
C/O LINDE PLC
FORGE, 43 CHURCH STREET WEST

(Street)
WOKING SURREY X0 GU216HT

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/18/2025 G V 25,000(1) D $0 455,542.502 D
Ordinary Shares 71,029 I 2010 Descendants Trust
Ordinary Shares 20,517 I 2012 Descendants Trust
Ordinary Shares 2,268 I In trust for children
Ordinary Shares 11,152.107 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 (2) (2) Ordinary Shares 1,029.658 1,029.658 D
Restricted Stock Units (3) (3) (3) Ordinary Shares 11,619.731 11,619.731 D
Restricted Stock Units (4) (4) (4) Ordinary Shares 11,513.507 11,513.507 D
Restricted Stock Units (5) (5) (5) Ordinary Shares 11,528.591 11,528.591 D
Restricted Stock Units (6) (6) (6) Ordinary Shares 24,425.651 24,425.651 D
Restricted Stock Units (7) (7) (7) Ordinary Shares 31,777.473 31,777.473 D
Restricted Stock Units (8) (8) (8) Ordinary Shares 46,458.924 46,458.924 D
Restricted Stock Units (9) (9) (9) Ordinary Shares 26,505.458 26,667.965 D
Stock Options (right to buy) $253.68(10) 03/08/2022(10) 03/08/2031(10) Ordinary Shares 133,465 133,465 D
Stock Options (right to buy) $173.13(11) 03/09/2021(11) 03/09/2030(11) Ordinary Shares 169,560 169,560 D
Stock Options (right to buy) $176.63(12) 03/20/2020(12) 03/20/2029(12) Ordinary Shares 177,605 177,605 D
Stock Options (right to buy) $154(13) 02/27/2019(13) 02/27/2028(13) Ordinary Shares 318,780 318,780 D
Stock Options (right to buy) $118.71(14) 02/28/2018(14) 02/28/2027 Ordinary Shares 74,850 74,850 D
Explanation of Responses:
1. Charitable gift of shares; no market transaction occurred.
2. The Restricted Stock Unit ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made.
3. Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
4. Restricted Stock Units that have vested in full but whose payout has been deferred to a future date.
5. Restricted Stock Units granted March 20, 2019, that have vested in full but whose payout has been deferred to a future date.
6. Restricted Stock Units granted February 27, 2018, that have vested in full but whose payout has been deferred to a future date.
7. Restricted Stock Unit award granted February 28, 2017, that has vested in full but whose payout has been deferred to a future date.
8. Restricted Stock Units granted February 28, 2017, that have vested in full but whose payout has been deferred to a future date.
9. Restricted Stock Unit award granted February 23, 2016, that has vested in full but whose payout has been deferred to a future date.
10. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
11. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
12. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
13. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.
14. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
Remarks:
Anthony M. Pepper as attorney-in-fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stephen F. Angel report on Form 4 for LIN?

He reported a disposition of 25,000 ordinary shares on 08/18/2025 described as a charitable gift and listed his remaining holdings.

How many Linde (LIN) shares does the reporting person hold after the transaction?

The filing shows 455,542.502 ordinary shares held directly after the reported transaction, plus indirect holdings in trusts and a 401(k).

Was the 25,000-share transaction a market sale?

No. The filing states it was a charitable gift and notes $0 as the transaction price, indicating no market sale.

Does the Form 4 disclose other equity awards for the reporting person?

Yes. The filing lists multiple restricted stock units (RSUs) and stock options with grant dates, vesting terms, expiration dates, and underlying share amounts.

What is the reporting person’s relationship to Linde plc?

The form indicates the reporting person is a Director of Linde plc.
Linde Plc

NASDAQ:LIN

LIN Rankings

LIN Latest News

LIN Latest SEC Filings

LIN Stock Data

188.32B
465.67M
0.26%
87.42%
1.13%
Specialty Chemicals
Industrial Inorganic Chemicals
Link
United Kingdom
WOKING SURREY